GenHealth.ai Launches AI-Powered Order Automation Solution for Home and Durable Medical Equipment (HME / DME) Providers
Revolutionizing DME Operations: Seamless Automation from Intake to Billing
BOSTON, MASSACHUSETTS / ACCESS Newswire / June 4, 2025 / GenHealth.ai today announced the launch of its AI-powered automation solution specially designed for Durable Medical Equipment (DME) and Home Medical Equipment (HME) providers, helping relieve the burden of complex workflows such as medical order intake, eligibility verification, and prior authorizations. This launch marks a major expansion of GenHealth.ai's mission to bring intelligent, scalable automation to healthcare operations-boosting accuracy, reducing delays, and accelerating access to care.
Developed in close partnership with early DME customers, GenHealth.ai's platform streamlines the medical order lifecycle using new advancements in AI and Large Language Models (LMMs)-combined with deep integrations into existing EMR and billing systems-specifically for DME and HME providers.
Key capabilities include:
Automated Patient Intake: Consolidates all incoming orders-fax, email, EHR, and portals-into a single inbox. Processes even handwritten forms and fills in data to billing systems and electronic medical records.Real-Time Coverage & Eligibility Checks: Verifies insurance coverage through clearinghouses or direct payer integrations, extracting key plan-level details like deductible status, coverage limits, and co-pays.Medical Necessity & Prior Auth Submission: Compares clinical documentation-such as physician notes-against payer policy requirements, identifying gaps in real time, ensuring every order is audit-ready before it hits the billing queue.Seamless Billing Integration: Pushes claim-ready orders directly into systems like Brightree and NikoHealth, eliminating rekeying and toggling between platforms.Deep Insight into Payment Analytics: Compare reimbursement rates against historical benchmarks and peer performance metrics using GenHealth's Large Medical Model (LMM).
Early Results: Less Manual Work. Higher Accuracy
Across early implementations, GenHealth.ai has delivered:
4x increase in orders processed per employee50% reduction in manual review time95%+ alignment with human utilization management (UM) decisions
"With AI, customers are able to bring on our AI agent to help their existing teams process more cases and increase revenue while reducing administrative costs." said Ethan Siegel, CPO. Ricky Sahu, CEO, added "DME providers deserve tools that reduce friction across every step of the order process-and they shouldn't have to rip out their systems to make it work. Our AI integrates into existing customer apps without disrupting how their teams work today."
Expanding the Vision for Smarter Healthcare Operations
In addition to the DME solution, GenHealth.ai has developed a prior authorization automation solution for providers, designed to accelerate access to high-cost therapies such as GLP-1s and chemotherapies. By combining AI, patient charts, and payer-specific coverage logic, the platform helps providers achieve faster patient-centered approvals-resulting in higher approval rates.
GenHealth.ai will be showcasing these capabilities live at the VGM Heartland Conference in Waterloo, IA, on June 10-11, 2025 and at ENDO 2025 in San Francisco, CA, on July 12-14, 2025.
About GenHealth.ai
GenHealth.ai is a healthcare automation company building AI-powered infrastructure for modern care delivery. The company's platform uses a proprietary Large Medical Model (LMM) to understand real-world clinical data, payer requirements, and operational workflows. GenHealth.ai helps providers, DME suppliers, and care teams reduce administrative burden, improve accuracy, and accelerate patient access to care-all through intelligent, end-to-end automation.
To learn more, contact hello@genhealth.ai or visit www.genhealth.ai
Contact Information
Mike Maseda Head of Operationsmarketing@genhealth.ai
SOURCE: Genhealth AI
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
4 days ago
- Miami Herald
GenHealth.ai Launches AI-Powered Order Automation Solution for Home and Durable Medical Equipment (HME / DME) Providers
Revolutionizing DME Operations: Seamless Automation from Intake to Billing BOSTON, MASSACHUSETTS / ACCESS Newswire / June 4, 2025 / today announced the launch of its AI-powered automation solution specially designed for Durable Medical Equipment (DME) and Home Medical Equipment (HME) providers, helping relieve the burden of complex workflows such as medical order intake, eligibility verification, and prior authorizations. This launch marks a major expansion of mission to bring intelligent, scalable automation to healthcare operations-boosting accuracy, reducing delays, and accelerating access to care. Developed in close partnership with early DME customers, platform streamlines the medical order lifecycle using new advancements in AI and Large Language Models (LMMs)-combined with deep integrations into existing EMR and billing systems-specifically for DME and HME providers. Key capabilities include: Automated Patient Intake: Consolidates all incoming orders-fax, email, EHR, and portals-into a single inbox. Processes even handwritten forms and fills in data to billing systems and electronic medical Coverage & Eligibility Checks: Verifies insurance coverage through clearinghouses or direct payer integrations, extracting key plan-level details like deductible status, coverage limits, and Necessity & Prior Auth Submission: Compares clinical documentation-such as physician notes-against payer policy requirements, identifying gaps in real time, ensuring every order is audit-ready before it hits the billing Billing Integration: Pushes claim-ready orders directly into systems like Brightree and NikoHealth, eliminating rekeying and toggling between Insight into Payment Analytics: Compare reimbursement rates against historical benchmarks and peer performance metrics using GenHealth's Large Medical Model (LMM). Early Results: Less Manual Work. Higher Accuracy Across early implementations, has delivered: 4x increase in orders processed per employee50% reduction in manual review time95%+ alignment with human utilization management (UM) decisions "With AI, customers are able to bring on our AI agent to help their existing teams process more cases and increase revenue while reducing administrative costs." said Ethan Siegel, CPO. Ricky Sahu, CEO, added "DME providers deserve tools that reduce friction across every step of the order process-and they shouldn't have to rip out their systems to make it work. Our AI integrates into existing customer apps without disrupting how their teams work today." Expanding the Vision for Smarter Healthcare Operations In addition to the DME solution, has developed a prior authorization automation solution for providers, designed to accelerate access to high-cost therapies such as GLP-1s and chemotherapies. By combining AI, patient charts, and payer-specific coverage logic, the platform helps providers achieve faster patient-centered approvals-resulting in higher approval rates. will be showcasing these capabilities live at the VGM Heartland Conference in Waterloo, IA, on June 10-11, 2025 and at ENDO 2025 in San Francisco, CA, on July 12-14, 2025. About is a healthcare automation company building AI-powered infrastructure for modern care delivery. The company's platform uses a proprietary Large Medical Model (LMM) to understand real-world clinical data, payer requirements, and operational workflows. helps providers, DME suppliers, and care teams reduce administrative burden, improve accuracy, and accelerate patient access to care-all through intelligent, end-to-end automation. To learn more, contact hello@ or visit Contact Information Mike Maseda Head of Operationsmarketing@ SOURCE: Genhealth AI press release
Associated Press
4 days ago
- Associated Press
GenHealth.ai Launches AI-Powered Order Automation Solution for Home and Durable Medical Equipment (HME / DME) Providers
Revolutionizing DME Operations: Seamless Automation from Intake to Billing BOSTON, MASSACHUSETTS / ACCESS Newswire / June 4, 2025 / today announced the launch of its AI-powered automation solution specially designed for Durable Medical Equipment (DME) and Home Medical Equipment (HME) providers, helping relieve the burden of complex workflows such as medical order intake, eligibility verification, and prior authorizations. This launch marks a major expansion of 's mission to bring intelligent, scalable automation to healthcare operations-boosting accuracy, reducing delays, and accelerating access to care. Developed in close partnership with early DME customers, 's platform streamlines the medical order lifecycle using new advancements in AI and Large Language Models (LMMs)-combined with deep integrations into existing EMR and billing systems-specifically for DME and HME providers. Key capabilities include: Early Results: Less Manual Work. Higher Accuracy Across early implementations, has delivered: 'With AI, customers are able to bring on our AI agent to help their existing teams process more cases and increase revenue while reducing administrative costs.' said Ethan Siegel, CPO. Ricky Sahu, CEO, added 'DME providers deserve tools that reduce friction across every step of the order process-and they shouldn't have to rip out their systems to make it work. Our AI integrates into existing customer apps without disrupting how their teams work today.' Expanding the Vision for Smarter Healthcare Operations In addition to the DME solution, has developed a prior authorization automation solution for providers, designed to accelerate access to high-cost therapies such as GLP-1s and chemotherapies. By combining AI, patient charts, and payer-specific coverage logic, the platform helps providers achieve faster patient-centered approvals-resulting in higher approval rates. will be showcasing these capabilities live at the VGM Heartland Conference in Waterloo, IA, on June 10-11, 2025 and at ENDO 2025 in San Francisco, CA, on July 12-14, 2025. About is a healthcare automation company building AI-powered infrastructure for modern care delivery. The company's platform uses a proprietary Large Medical Model (LMM) to understand real-world clinical data, payer requirements, and operational workflows. helps providers, DME suppliers, and care teams reduce administrative burden, improve accuracy, and accelerate patient access to care-all through intelligent, end-to-end automation. To learn more, contact [email protected] or visit Contact Information Mike Maseda Head of Operations [email protected] SOURCE: Genhealth AI press release
Miami Herald
5 days ago
- Miami Herald
Palantir reacts to controversial New York Times allegations
As the AI war between big tech companies continues to heat up, it'll be no surprise to see big moves being made - and toes getting stepped on. OpenAI is a perfect example of the type of disruptive tech company that will change the world, but not without some missteps on the way up. Don't miss the move: Subscribe to TheStreet's free daily newsletter With OpenAI, the big complaint people have leveled is that its model steals people's content from the internet and uses it to train their Large Language Models, or LLMs, without permission from the people who created that content. In fact, The New York Times has sued OpenAI for this very thing. Now, The Times is calling out another tech company for a project it's completing for the U.S. government. That company is Palantir (PLTR) , the data analytics and AI software firm that's getting more and more attention lately, thanks to its steadily rising stock and AI expertise. According to The Times, a Palantir product called Foundry has been added to four federal agencies, including DHS and the Health and Human Services Department, as reported to them by government officials. Foundry is used to organize and analyze data, and The Times quotes sources that allege Trump could use it to further his own political agenda. While other big tech stocks have wobbled in the headwinds of President Trump's tariffs, Palantir has continued to prove itself as one to watch. Originally a data analytics and enterprise software company, Palantir has since moved into other markets, one being supplying defense contracting technology to the U.S. military. The New York Times report published May 30 states that in addition to Palantir's work with the Trump Administration using Foundry, Palantir has received more than $113 million in federal funding, according to public record, and that Palantir representatives are also in talks with the Social Security Administration and the Internal Revenue Service about buying its technology. Related: Palantir stock makes history as analysts revamp price target "Mr. Trump could potentially use such information to advance his political agenda by policing immigrants and punishing critics, Democratic lawmakers and critics have said," The NYT story reads. "Privacy advocates, student unions, and labor rights organizations have filed lawsuits to block data access, questioning whether the government could weaponize people's personal information." The article also claims that some Palantir employees have been made uneasy by the company's decision to work with the Trump administration and that it "risks becoming the face of Mr. Trump's political agenda." Palantir addressed the NYT story in a tweet shared on X on June 3, denying the allegations. "The recently published article by The New York Times is blatantly untrue," the tweet reads. "Palantir never collects data to unlawfully surveil Americans, and our Foundry platform employs granular security protections. If the facts were on its side, The New York Times would not have needed to twist the truth." People had mixed reactions to the statement in the tweet thread, with some believing in Palantir and some less than convinced by what the company had to say. "Palantir is trusted by top military and intelligence organizations. How can people believe it has poor security protections?" said X user @sageozzeus. X user DanielvsBabylon was quick to point out the use of a specific word in the statement, saying, "'Unlawfully,' which means they operate in a legal grey area." Some users went into even more detail. "Stating that you don't 'unlawfully' surveil Americans is deliberately evasive," X user @DoniTheMisfit said. "It doesn't deny surveillance - it simply implies government authorization, which is not the same as public consent or constitutional legitimacy." "Likewise, referencing 'granular security protections' does not equate to individual privacy. It signals internal control over data - not limits on its collection or use. This isn't transparency - it's calculated language meant to deflect scrutiny while maintaining centralized access to sensitive information." Related: Palantir leader has shocking take on Elon Musk and DOGE The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
